Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

When Tamika Young was promoted to the top marketing gig at dating app Hinge last December, she stipulated that she wanted to change the job title. Young wouldn’t just become the CMO—she would become ...

Section 1. Purpose. The United States continues to lead the world in Artificial Intelligence (AI) because of the enormous talent and innovation of our AI industry, and because we refuse to stifle this ...

We’re over two months into the fantasy baseball season, and we’ve started weighing the advanced metrics from the current season more heavily. The Royals, Reds, Rays and Astros have been the teams with ...

MADISON, Wis. (WBAY) - Gov. Tony Evers and the Wisconsin Department of Workforce Development announced applications are now open to give workers job training in advanced manufacturing or artificial ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) ("Oklo," or "the Company"), an advanced nuclear technology company, today announced that Oklo has been selected by the U.S. Department of ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

Last week, we talked about how Pirates’ hitters were going to face juicy matchups. Brandon Lowe (2 HR, .346 BA), Spencer Horwitz (2 HR, .333 BA), Oneil Cruz (1 HR, .200) and Konnor Griffin (3 SB, .308 ...

Washington has emerged from a month of cherry blossom-themed gatherings and festivals to find a wide-ranging set of weekend activities, including the return of Filmfest DC and parades and concerts to ...

Did WTOP’s coverage of Artemis II’s return to Earth get your cosmic juices flowing? If so, you may want to set your alarm early. CLICK PHOTO TO ENLARGE: Comet C/2025 R3 in my Unistellar telescope on ...

Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with the ...

— In the proof-of-concept study, ALTO-101 did not achieve statistical significance on primary endpoint; signals observed across EEG measures including near-significant improvement in theta-ITC ...